BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paternain A, García-Velloso MJ, Rosales JJ, Ezponda A, Soriano I, Elorz M, Rodríguez-Otero P, Aquerreta JD. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT. Eur J Radiol 2020;133:109403. [PMID: 33202373 DOI: 10.1016/j.ejrad.2020.109403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrarazzo G, Chiola S, Capitanio S, Donegani MI, Miceli A, Raffa S, Tagliafico AS, Morbelli S, Bauckneht M. Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting. Diagnostics (Basel) 2021;11:230. [PMID: 33546455 DOI: 10.3390/diagnostics11020230] [Reference Citation Analysis]
2 Mena E. Modern radiographic imaging in multiple myeloma, what is the minimum requirement? Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.01.007] [Reference Citation Analysis]
3 Lin G, Zong X, Li Y, Tan W, Sun W, Zhang S, Gan Y, Zeng H. Whole-Body MRI Is an Effective Imaging Modality for Hematological Malignancy Treatment Response Assessment: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:827777. [DOI: 10.3389/fonc.2022.827777] [Reference Citation Analysis]
4 Kaddoura M, Dingli D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Hwa L, Fonder A, Hobbs M, Hayman S, Lust J, Leung N, Go RS, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Broski SM, Rajkumar V, Kumar S. Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma. Blood Adv 2021;5:2753-9. [PMID: 34242392 DOI: 10.1182/bloodadvances.2020004131] [Reference Citation Analysis]